14/02/2016 03:08:36 1-888-992-3836 (toll free) Free Membership Login

Inovio Pharmaceuticals, Inc. News (NASDAQ:INO)

DateTimeSource
Headline
02/02/20168:00AMGLOBEInovio Pharmaceuticals to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Feb. 02, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that management will participate at three upcoming investor conferences in February: BIO CEO & Investor ConferenceFebruary 8-9, 2016New York, NYRBC Capital Markets Global Healthcare ConferenceFebruary... More...>>
01/28/20167:00AMGLOBEInovio Pharmaceuticals and GeneOne Life Science Initiate Patient Recruitment for MERS Vaccine Trial
PLYMOUTH MEETING, Pa., Jan. 28, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced the beginning of recruitment for its collaborative vaccine study for MERS (Middle East Respiratory Syndrome). Inovio and GeneOne Life Science Inc. (KSE:011000) are co-developing Inovio’s MERS vaccine (GLS-5300... More...>>
01/22/20165:00AMGLOBEGeneOne Life Science and Inovio Pharmaceuticals to Collaborate on Zika Virus Vaccine Development
SEOUL, South Korea, Jan. 22, 2016 (GLOBE NEWSWIRE) -- GeneOne Life Science (KSE:011000) today announced the initiation of a collaborative research program with Inovio Pharmaceuticals (NASDAQ:INO) to test and advance a DNA-based vaccine for preventing and treating the emerging and virulent Zika virus infection.   Inovio... More...>>
01/19/20168:00AMGLOBEInovio Pharmaceuticals Awarded Grant to Advance Needle-Free Vaccine Delivery Device
PLYMOUTH MEETING, Pa., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today it has been selected to receive a $500,000 grant from the U.S. Army’s Small Business Innovation Research (SBIR) program to further advance the development of Inovio’s next generation delivery device capable... More...>>
01/05/20168:00AMGLOBEInovio Pharmaceuticals to Present at Biotech Showcase
PLYMOUTH MEETING, Pa., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that Dr. J. Joseph Kim, President and CEO, will give a corporate presentation on Tuesday, January 12th at 9:30AM PST at Biotech Showcase 2016. Dr. Kim will also participate on a Biotech Showcase panel entitled... More...>>
01/04/20168:00AMGLOBEInovio Pharmaceuticals Adds Dr. Prakash Bhuyan to VGX-3100 Leadership Team for HPV-Related Dysplasia
PLYMOUTH MEETING, Pa., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today it has appointed Prakash Bhuyan, M.D, Ph.D., as Vice President, Clinical Development. Dr. Bhuyan will lead the clinical development of Inovio’s programs to treat HPV-related pre-cancers (dysplasia). Inovio... More...>>
12/04/20158:38AMTMFThe 3 Most Important Drugs in Inovio Pharmaceuticals' Pipeline
http://www.fool.com/investing/general/2015/12/04/the-3-most-important-drugs-in-inovio-pharmaceutica.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub More...>>
11/23/20158:00AMGLOBEInovio Pharmaceuticals to Present at Piper Jaffray Healthcare Conference
PLYMOUTH MEETING, Pa., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today reported that Dr. J. Joseph Kim, President and CEO, will participate in the Piper Jaffray 27th Annual Healthcare Conference on Wednesday, December 2nd at 3:30PM ET. A live and archived version of Dr. Kim’s fireside... More...>>
11/19/20159:00AMGLOBEGeneOne Life Science and Inovio Pharmaceuticals’ MERS Vaccine Approved for First-in-Human Study
SEOUL, South Korea, Nov. 19, 2015 (GLOBE NEWSWIRE) -- GeneOne Life Science Inc. (KSE:011000) today announced that the U.S. Food and Drug Administration has cleared the first-in-human clinical study of its collaborative vaccine for MERS (Middle East Respiratory Syndrome). GeneOne Life Science and Inovio Pharmaceuticals... More...>>
11/12/20152:32PMTMFInovio Pharmaceuticals Produces a Rare Quarterly Profit, but Don't Get Too Excited Just Yet
http://www.fool.com/investing/general/2015/11/12/inovio-pharmaceuticals-produces-a-rare-quarterly-p.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub More...>>
11/10/20153:17PMGLOBEGeneOne Life Science and the Walter Reed Army Institute of Research Partner to Develop MERS Vaccine
SEOUL, South Korea and SILVER SPRING, Md., Nov. 10, 2015 (GLOBE NEWSWIRE) -- GeneOne Life Science Inc. (KSE:011000) today announced that it has signed a cooperative research and development agreement with the Walter Reed Army Institute of Research (WRAIR) to advance GLS-5300, GeneOne’s DNA vaccine for MERS (Middle East... More...>>
11/10/20158:02AMTMFHere's Why Inovio Pharmaceuticals Had the Cure for Investors' Ills in October
http://www.fool.com/investing/general/2015/11/10/heres-why-inovio-pharmaceuticals-had-the-cure-for.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub More...>>
11/09/20157:00AMGLOBEInovio Pharmaceuticals Reports 2015 Third Quarter Results
PLYMOUTH MEETING, Pa., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today reported financial results for the quarter ended September 30, 2015. Total revenue was $24.2 million and $34.6 million for the three and nine months ended September 30, 2015, compared to $1.8 million and $8.0 million... More...>>
11/05/20158:00AMGLOBEInovio’s INO-3112 Shows Robust Immune Responses in Patients With Head & Neck Cancer
PLYMOUTH MEETING, Pa., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today an interim data analysis showing that its INO-3112 DNA-based immunotherapy generated specific T-cell responses and was well tolerated in all evaluable patients with head and neck cancer associated with human... More...>>
10/30/20153:06PMTMFIs Inovio Pharmaceuticals a Late Bloomer?
http://www.fool.com/investing/general/2015/10/30/is-inovio-pharmaceuticals-a-good-long-term-buy.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub More...>>
10/26/20158:00AMGLOBEInovio Pharmaceuticals to Host Third Quarter 2015 Financial Results Conference Call November 9, 2015
PLYMOUTH MEETING, Pa., Oct. 26, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the Company will host its third quarter 2015 financial results conference call and live webcast on Monday, November 9 at 8:30 AM ET. A live and archived version of the webcast presentation will be available... More...>>
10/19/20158:00AMGLOBEInovio and Partner Advance MERS Vaccine
Inovio Affiliate GeneOne Files Investigational New Drug Application No vaccine exists for MERS virus, which has killed 40% of those infected PLMOUTH MEETING, Pa., Oct. 19, 2015 (GLOBE NEWSWIRE) -- GeneOne Life Science Inc. (KSE:011000), which partnered with Inovio Pharmaceuticals, Inc. (NASDAQ: INO) to develop Inovio’s... More...>>
09/30/20158:00AMGLOBEInovio to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Sept. 30, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that management will participate at three upcoming investor conferences in October and November: Aegis Growth Conference October 7-9, 2015 Las Vegas, Nevada Brean Capital Life Sciences Summit One-on-one meetings... More...>>
09/21/20158:46PMGLOBEInovio's Chief Operating Officer Selected by PharmaVoice as One of the Most Inspirational Leaders in the Global Industry
PLYMOUTH MEETING, Pa., Sept. 15, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that PharmaVoice, one of the leading industry publications in the life sciences industry, has selected Dr. Niranjan Sardesai as one of its 100 most inspiring leaders of 2015. Dr. Sardesai is the Chief Operating... More...>>
09/21/20158:46PMGLOBEInovio Pharmaceuticals Announces First Patient Dosed With Universal HIV Vaccine
PLYMOUTH MEETING, Pa., Sept. 8, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the first patient has been dosed in a phase I trial to evaluate safety and tolerability of PENNVAX®-GP, Inovio's "universal" DNA vaccine for HIV. This human study is in collaboration with the HIV... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V:us D:20160214 08:08:38